Payload to Patient: Metabolomics in ADC and Immuno-Oncology
In this episode of the ChatGJP series, Panome Bio CSO Dr. Gary J. Patti joins Chris Eden to explore real-world applications of metabolomics in antibody–drug conjugates (ADCs) and immuno-oncology. The discussion covers how untargeted metabolomics can identify early biomarkers of drug efficacy and toxicity, stratify tumors based on metabolic phenotypes, and reveal metabolic interactions between cancer and immune cells within the tumor microenvironment.
Have a Question?
Your privacy is important to us.
We’ll never share your information.